 Welcome folks, this is the 4pm market update with Jacob Shoup filling in for Tom O'Brien. He will be back tomorrow. Before the show ended, I was speaking a little bit about Novo Nordus. They got hit with an FDA, an FDA Form 483 at one of their plants. Now it's not down 50% today, I'm not sure what the discrepancy is here. It's up a little bit at the close at 1.27%, let me give the fresher numbers, 1.31%. So it's not hit heavily. Now there's already a shortage on their drugs, so it's unclear whether or not this hit is going to impact them. What it was is they didn't have any limits on microbial, excuse me, they didn't have any microbial control limits, which was substantial, especially if you're making things like pharmaceuticals or that things people are going to ingest. They've had to start producing some Ogovi as well, when before they were kind of contracting that out. So it'll be interesting to see what happens with that. Now this is going to impact Ogovi and Ozenpik. So that's what we have going on with Novo Nordisk and it really didn't affect them too much and again this is kind of strange, I don't know what that 50% is. Some interesting news that's happening, now this isn't a public company but I still think it's kind of cool. This is coming out of Elon Musk as Neuralink is actually about to begin testing on people with ALS and other disabilities. Now the British have developed something as well, it's a chip that they put into people and it's people with tremors that completely stops it. It's actually a really fascinating kind of piece of technology and so Neuralink is about to be testing on people as well. They're putting a mesh over people's brains and this is going to be aimed at people with cervical spinal cord injuries and particularly ALS and probably other motor diseases that inhibit motor functions. So I think that is fascinating. Amazon, now this isn't a big jump for them but it's interesting to see, let's take a look real quick. We have time, down just a little bit, well they're Alexa, you want to put that in your home is going to be a little bit more conversational with you now so we're going to use an AI for the big things. Folks, thank you so much for joining me, we have Tommy starting tomorrow at 9am and we have the standard programming throughout the rest of the day with the man Tom O'Brien at 3pm. Have a great rest of your day folks.